Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2019, XLVII/279: 111-113 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2019, XLVII/279: 111-113

Title: Vitamin D and Hashimoto’s disease 

Authors: Jamka M, Ruchała M, Walkowiak J. 

More details

07/279

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Vitamin D and Hashimoto’s disease

Jamka M1, Ruchała M2, Walkowiak J1.

1Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poland; 2Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poland

It is probably that vitamin D may play an important role in the pathogenesis of Hashimoto’s disease. Previous studies have shown a higher incidence of vitamin D deficiencies in patients with Hashimoto’s disease compared to healthy subjects. Probably the severity of Hashimoto’s disease may affect serum 25-hydroxycholecalciferol (25(OH)D) concentrations. In addition, a negative correlation between serum 25(OH)D concentrations and the level of antithyroid antibodies was observed. Moreover, vitamin D supplementation seems to be effective in reducing the levels of thyroid peroxidase (TPO) antibodies both in patients with deficiency and with normal concentrations of vitamin D. However, further studies are needed to more accurately determine the effect of vitamin D supplementation on the Hashimoto’s disease.

Key words: vitamin D, cholecalciferol, Hashimoto’s disease, autoimmune thyroiditis

Pol Med J, 2019; XLVII (279); 111–113